Middle East and Africa Hemostasis Analyzers Market

Market Introduction

Hemostasis analyzers are devices that measure clotting mechanisms of hemostasis to detect clotting deficiencies and facilitate the treatment of patients with an excess bleeding condition by medical practitioners.  Constant technical advancement has led to the launch of many innovative drugs, and instruments such as high-performance hemostasis analyzers are projected to fuel demand growth for hemostasis analyzers.

The report provides trends prevailing in the Middle East and Africa hemostasis analyzers market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to rising number of cardiovascular diseases and rise in the geriatric population are the key factors driving the market growth. However, the market is expected to experience slow growth during the forecast period owing to high cost of fully automated hemostasis analyzer.

A rising number of medications imposing multiple diagnostic and therapeutic challenges on stressed healthcare systems, leading to a rise in medical devices and pharmaceuticals. Also, the increasing number of cases of chronic conditions has increased, which resulted in an increased use of drugs for combating the virus. During the widespread COVID-19 pandemic, there have been worries about the potential of certain blood pressure medications such as angiotensin converting enzyme inhibitors (ACEi) and angiotensin-converting blockers (ARB). The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses the membrane-bound angiotensin-converting enzyme 2 (ACE2) receptors to facilitate entry into the host cell. This pandemic enhanced the business operation of the various drug manufacturers operating in the hemostasis analyzers market in the region.

Middle East and Africa Hemostasis Analyzers Strategic Insights

Strategic insights for the Middle East and Africa Hemostasis Analyzers provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East and Africa Hemostasis Analyzers Report Scope

Middle East and Africa Hemostasis Analyzers Regional Insights

The geographic scope of the Middle East and Africa Hemostasis Analyzers refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Middle East and Africa hemostasis analyzers market in the Middle East and Africa is expected to grow from US$ 140.69 million in 2021 to US$ 251.51 million by 2028; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028.  Older people are prone to heart diseases due to weak immunity and other health problems. General aging factors lead to stiffening heart and blood vessels that result in heart disorders. As the age grows, the systolic blood pressure also rises, leading to an incidence of cardiovascular diseases. Thus, in people aged 75 years and above, high blood pressure is a common risk factor for heart conditions. Coronary artery disease and heart failure are the other causes. Although the incidence of arrhythmias encompasses people of all age groups, it is rising significantly among the geriatric population. The elderly population is more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. The primary reason for the disease is related to the structural and functional changes in the cardiovascular system associated with aging. The rise in the global geriatric population is leading to a surge in cardiovascular diseases, which, in turn, is propelling the demand for hemostasis analyzers, supporting the market.

Key Market Segments

In terms of product type, the laboratory analyzer segment accounted for the largest share of the Middle East and Africa hemostasis analyzers market in 2020.  In terms of test, the d-dimer test segment accounted for the largest share of the Middle East and Africa hemostasis analyzers market in 2020. In terms of end user, the hospital/clinics segment accounted for the largest share of the Middle East and Africa hemostasis analyzers market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the Middle East and Africa  hemostasis analyzers market in Middle East and Africa  are company websites, annual reports, financial reports, national government documents, and statistical databases, among others. Major companies listed in the report are Siemens Healthineers AG , Abbott  , Sysmex Corporation , Nihon Kohden Corporation ,THERMO FISHER SCIENTIFIC INC. ,HOFFMANN-LA ROCHE LTD. , Instrumentation Laboratory Company.

Reasons to buy report

• To understand the Middle East and Africa  hemostasis analyzers market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East and Africa hemostasis analyzers markets.
• Efficiently plan M&A and partnership deals in the Middle East and Africa  hemostasis analyzers market by identifying market segments with the most promising probable sales
• Helps to make knowledgeable business decisions from a perceptive and comprehensive analysis of the market performance of various segments for the Middle East and Africa hemostasis analyzers market.
• Obtain market revenue forecast for market by various segments from 2021-2028 in the Middle East and Africa region.

Middle East and Africa Hemostasis Analyzers Market Segmentation

By Product Type

• Laboratory Analyzer
  • Automated Systems
  • Semi-Automated Systems
  • Manual Systems
• Point-of-Care Testing Systems

By Test

• Activated Partial Thromboplastin Time
• D-Dimer Test
• Fibrinogen Test
• Prothrombin Time (PT) Test
• Others

By End User

• Hospitals/ Clinics
• Independent Diagnostic Laboratories
• Home Care Setting
• Others

By Country

• Middle East and Africa  
  •  UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Companies Mentioned -

•  Siemens Healthineers AG
• Abbott 
•  Sysmex Corporation
• Nihon Kohden Corporation
• THERMO FISHER SCIENTIFIC INC.
• HOFFMANN-LA ROCHE LTD.
• Instrumentation Laboratory Company